CDC reports the age‑adjusted U.S. drug overdose death rate fell 4% from 2022 to 2023 (31.3 per 100,000; 105,007 deaths). Rates declined for people 15–54 and for White non‑Hispanic people, but rose for adults 55+ and for Black non‑Hispanic and Native Hawaiian/Other Pacific Islander non‑Hispanic groups. Deaths involving synthetic opioids (e.g., fentanyl) decreased, while cocaine and psychostimulant‑involved deaths continued to rise.
— This shifts the overdose narrative beyond fentanyl, signaling a need to target rising stimulant harms and address growing demographic disparities in overdose risk.
2026.01.04
92% relevant
The Wikipedia article is essentially a compiled, updated CDC time series showing the national overdose trajectory (peak ~2022, provisional counts for 2023–2025, role of synthetic opioids/fentanyl). That directly matches the existing idea’s claim that year‑to‑year shifts (including provisional declines and stimulant trends) require granular, disaggregated CDC data to interpret policy implications.
2026.01.04
72% relevant
The article reports a small decline in fentanyl deaths in 2023 (−1.4%) while warning about provisional 2024 undercounts; this links to the existing observation that overdose trends can shift year‑to‑year and that declines in one category can mask rises in others (stimulants, polysubstance involvement).
2025.10.07
100% relevant
CDC NCHS Data Brief No. 522 (NVSS, 2023): overall rate down 4%, fentanyl‑class deaths down, cocaine and psychostimulant deaths up, with age and race/ethnicity divergences.
2024.08.21
92% relevant
NIDA reports 105,007 overdose deaths in 2023 (down from 2022), opioid-involved deaths fell to 79,358, and deaths involving cocaine rose to 29,449 and psychostimulants to 34,855, with ~70% of stimulant deaths co‑involving illicit fentanyl—exactly the pattern described.
2023.03.08
80% relevant
The report documents large percentage increases in psychostimulant‑involved deaths (317% 2013–2019) and shows stimulants and cocaine rising even separate from synthetic‑opioid involvement, supporting the idea that the overdose crisis is diversifying beyond fentanyl.
2018.03.29
90% relevant
The MMWR furnishes the empirical basis for the later observation about shifting overdose composition: it documents the doubling of synthetic‑opioid deaths and increases in cocaine and psychostimulant deaths from 2015→2016, which is the early stage of the stimulant‑and‑synthetic‑opioid pattern the existing idea tracks.